Safety Study of Oral Edaravone Administered in Subjects With ALS

PHASE3CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

October 7, 2021

Study Completion Date

October 7, 2021

Conditions
ALS
Interventions
DRUG

MT-1186

"* An initial treatment cycle with daily dosing for 14 days, followed by a 14-day drug free period~* Subsequent treatment cycles with daily dosing for 10 days out of a 14-day period, followed by a 14 day drug free period. Treatment cycles are every 4 weeks."

Trial Locations (53)

6001

CHU de NICE Hopital Pasteur 2 -Centre de Reference des Maladies -Neuromusculaires & SLA-Pole Neurosciences Cliniques, Nice

10126

Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA), Turin

15212

Alleghany General Hospital, Pittsburgh

17025

Penn State Hershey Children's Hospital, Hershey

19140

Lewis Katz School of Medicine at Temple University, Philadelphia

20132

Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele), Milan

20162

Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre), Milan

21205

Johns Hopkins University, Baltimore

30625

Medizinische Hochschule Hannover, Hanover

33400

Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux

38018

Wesley Neurology Clinic, P.C., Cordova

53226

Medical College of Wisconsin, Milwaukee

55805

Essentia Institute of Rural Health, Duluth

65191

Deutsche Klinik fuer Diagnostik, Wiesbaden

69677

Hopital Pierre Wertheimer - Hopital Neurologique, Bron

72758

Woodland Research Northwest, Rogers

75214

Texas Neurology, PA, Dallas

77030

Houston Methodist Neurological Institute, Houston

78229

UT Health Science Center San Antonio, San Antonio

80045

University of Colorado Anschutz Medical Campus, Aurora

85013

St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center, Phoenix

85028

Neuromuscular Research Center, Phoenix

87025

Centre Hospitalier Esquirol, Limoges

94115

Sutter Health, San Francisco

98195

University of Washington Medical Center, Seattle

32610-3633

UF Health Cancer Center, Gainesville

30317-2819

Emory University - School of Medicine, Atlanta

48109-5223

University of Michigan - ALS Center of Excellence, Ann Arbor

48168-9493

University of Michigan Health System (UMHS) - Allergy Clinic - Northville Health Center Location, Northville

68506-2960

Neurology Associates, P.C - Lincoln, Lincoln

27157-0001

Wake Forest University Baptist Medical Center (WFUBMC) - The J. Paul Sticht Center on Aging and Rehabilitation, Winston-Salem

T2N 4Z6

Heritage Medical Research Clinic - University Of Calgary, Calgary

T6G 2B7

University of Alberta - Walter C Mackenzie Health Sciences Centre (WCM), Edmonton

J4V 2J2

Recherche Sepmus, Inc, Greenfield Park

H3A 2B4

Montreal Neurological Institute and Hospital, Montreal

06202

CHU Nice-Hospital Archet I, Nice

480-1195

Aichi Medical University Hospital, Nagakute-shi

260-8712

National Hospital Organization Chiba-East-Hospital, Chiba

819-8585

Murakami Karindoh Hospital, Fukuoka

960-1295

Fukushima Medical University Hospital, Fukushima

063-0005

National Hospital Organization Hokkaido Medical Center, Sapporo

920-0192

National Hospital Organization Iou National Hospital, Kanazawa

761-0793

Kagawa University Hospital, Kita-gun

252-0375

Kitasato University Hospital, Sagamihara

236-0004

Yokohama City University Hospital, Yokohama

861-1196

National Hospital Organization Kumamoto Saishun Medical Center, Koshi-shi

616-8255

National Hospital Organization Utano Hospital, Kyoto

980-8574

Tohoku University Hospital, Sendai

951-8520

Niigata University Medical And Dental Hospital, Niigata

560-8552

National Hospital Organization Toneyama Medical Center, Toyonaka-shi

520-2192

Shiga University of Medical Science Hospital, Ōtsu

420-8688

National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka

113-8431

Juntendo University Hospital, Bunkyo-ku

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY